Listen to The Lancet

Two-drug regimen for HIV

11.10.2018 - By The LancetPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Jessamy Bagenal and Kimberly Smith discuss implications arising from the Gemini study, which shows how a two-drug combination is not inferior to a conventional three-drug regimen in the treatment of HIV.

More episodes from Listen to The Lancet